During the past decade, Toyohashi Heart Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Toyohashi Heart Center" #1 sponsor was "Society for Advancement of Coronary Intervention Research" with 2 trials, followed by "Abbott Medical Devices" with 1 trials sponsored, "Associations for Establishment of Evidence in Interventions" with 1 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored and "Medtronic Italia" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Toyohashi Heart Center" #1 collaborator was "Abbott Medical Devices" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Asahi Intech" with 1 trials as a collaborator, "Cordis Corporation" with 1 trials as a collaborator and "Japan Lifeline" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Toyohashi Heart Center" are "Coronary Artery Disease" (2 trials), "Ischemic Heart Disease" (2 trials), "Arrhythmias, Cardiac" (1 trials), "Atrial Fibrillation" (1 trials) and "Bleeding" (1 trials). Many other conditions were trialed in "Toyohashi Heart Center" in a lesser frequency.

Most popular intervention types in "Toyohashi Heart Center" are "Device" (10 trials), "Drug" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cardiac Resynchronization Therapy-Defibrillator (CRT-D)" (1 trials), "Cypher stent" (1 trials), "EES vs. SES" (1 trials), "Implantable Cardioverter-Defibrillator (ICD)" (1 trials) and "Implantable Loop Recorder (ILR)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Toyohashi Heart Center" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Toyohashi Heart Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Toyohashi Heart Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Toyohashi Heart Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 4 trials that are defined as “Not Applicable".